Why We Need Continuous Pharmaceutical Manufacturing and How to Make it Happen: A Summary of Thoughts from the International Symposium on Continuous Manufacturing.

Clive Badman,Charles L Cooney, Robert T Haslam,Alastair Florence,Konstantin Konstantinov,Markus Krumme,Salvatore Mascia,Moheb Nasr,Bernhardt L Trout, Raymond F Baddour

Journal of Pharmaceutical Sciences（2019）

引用 63|浏览22

暂无评分

摘要

We make the case for why continuous pharmaceutical manufacturing is essential, what the barriers are, and how to overcome them. To overcome them, government action is needed in terms of tax incentives or regulatory incentives that affect time.

查看译文

关键词

continuous manufacturing,advanced manufacturing,model-based control,tax incentives,regulatory incentives,personalized medicine,stock-outs,stockpiles,PAT,quality

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要